Maple Capital Management’s Colgate-Palmolive CL Stock Holding History

Maple Capital Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.8M	Buy	182,704 +2,287	+1%	+$200K	0.99%	30
2026 Q1	$15.4M	Buy	180,417 +2,291	+1%	+$204K	1.03%	30
2025 Q4	$14.1M	Buy	178,126 +4,494	+3%	+$352K	0.89%	29
2025 Q3	$13.9M	Buy	173,632 +9,555	+6%	+$815K	0.91%	30
2025 Q2	$14.9M	Buy	164,077 +22,207	+16%	+$2.03M	1.02%	31
2025 Q1	$13.3M	Buy	141,870 +15,138	+12%	+$1.36M	1.03%	30
2024 Q4	$11.5M	Buy	126,732 +4,504	+4%	+$430K	0.85%	31
2024 Q3	$12.7M	Buy	122,228 +10,281	+9%	+$1.05M	0.97%	31
2024 Q2	$10.9M	Buy	+111,947	New	+$10.3M	0.88%	32
2014 Q3	–	Sell	-3,830	Closed	-$261K	–	123
2014 Q2	$261K	Hold	3,830	–	–	0.1%	108
2014 Q1	$248K	Hold	3,830	–	–	0.1%	113
2013 Q4	$250K	Sell	3,830 -60	-2%	-$3.84K	0.1%	116
2013 Q3	$231K	Hold	3,890	–	–	0.1%	113
2013 Q2	$223K	Buy	+3,890	New	+$231K	0.1%	110

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Maple Capital Management's CL Position: Q2 2026 in Review

Maple Capital Management increased its Colgate-Palmolive (CL) stake by 1.3% in Q2 2026, buying an estimated $200K and bringing the position to 182,704 shares worth $16.8M. The position accounts for 0.99% of the portfolio, ranked #30.

Maple Capital Management first reported a position in CL in Q2 2013 and has held it in 14 quarters since. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Maple Capital Management held 182,704 shares of Colgate-Palmolive worth $16.8M as of Q2 2026.
Maple Capital Management bought 2,287 Colgate-Palmolive shares in Q2 2026, an estimated $200K.
Colgate-Palmolive made up 0.99% of Maple Capital Management's portfolio in Q2 2026, its #30 holding.
Maple Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 14 quarters since.
2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Maple Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.